René Hersperger

Title: The Innovative Contributions of René Hersperger

Introduction

René Hersperger is a notable inventor based in Münchenstein, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of 2 patents, his work has implications for various medical applications.

Latest Patents

Hersperger's latest patents include innovative compounds that serve as chemokine receptor antagonists. One of his notable inventions is a compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, where the variants R, R9, Z, X, Q, and Y are defined in the specification. Another significant patent involves 2-aminopyrimidine derivatives and their medical use. This patent describes a compound of formula I or a pharmaceutically acceptable salt, ester, or prodrug thereof, with specific variables defined in the specification. The patent further discloses methods for inhibiting IKK activity and TNF production using the compound, as well as its use as a pharmaceutical and in the manufacture of a medicament for immunosuppressant or anti-inflammatory purposes.

Career Highlights

Throughout his career, René Hersperger has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Hersperger has collaborated with several professionals in his field, including colleagues Philipp Janser and Birgit Bollbuck. These collaborations have likely enhanced the quality and impact of his work.

Conclusion

René Hersperger's innovative contributions to pharmaceutical science, particularly through his patents, demonstrate his commitment to advancing medical research. His work continues to influence the development of new therapeutic agents.